Tenascin-C in primary malignant melanoma of the skin.

Ilmonen, S; Jahkola, T; Turunen, J P; Muhonen, T; Asko-Seljavaara, S

Ilmonen, S; Jahkola, T; Turunen, J P; Muhonen, T; Asko-Seljavaara, S.

Affiliation

Ilmonen S; Department of Plastic Surgery, Helsinki University Hospital, Helsinki, Finland. suvi.ilmonen@hus.fi

Histopathology ; 45(4): 405-11, 2004 Oct.

Article in En | MEDLINE | ID: mdl-15469480

Subject(s)

Melanoma/metabolism; Skin Neoplasms/metabolism; Tenascin/biosynthesis; Adult; Aged; Aged, 80 and over; Female; Humans; Immunohistochemistry; Inflammation/metabolism; Inflammation/pathology; Male; Melanoma/mortality; Melanoma/pathology; Middle Aged; Neoplasm Invasiveness/pathology; Prognosis; Skin Neoplasms/mortality; Skin Neoplasms/pathology; Survival Analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tenascin / Melanoma Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2004 Document type: Article

Search on Google

XML

PubMed Links